Home > SWOT Analysis > OSI Pharma (OSIP) SWOT Analysis





OSI Pharma (OSIP) SWOT Analysis Profile

OSI Pharmaceuticals, Inc., founded in 1983, is a bioTechnology company that researches and develops molecular targeted therapies for oncology, diabetes, and obesity in the United States and internationally. Its flagship product, Tarceva, is used for the treatment of advanced non-small cell lung cancer and metastatic pancreatic cancer. OSI Pharmaceuticals, Inc. is headquartered in Melville, New York. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email